نتایج جستجو برای: medulloblastoma

تعداد نتایج: 5231  

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2010
Till Milde Ina Oehme Andrey Korshunov Annette Kopp-Schneider Marc Remke Paul Northcott Hedwig E Deubzer Marco Lodrini Michael D Taylor Andreas von Deimling Stefan Pfister Olaf Witt

PURPOSE Medulloblastomas are the most common malignant brain tumors in childhood. Survivors suffer from high morbidity because of therapy-related side effects. Thus, therapies targeting tumors in a specific manner with small molecules such as histone deacetylase (HDAC) inhibitors are urgently warranted. This study investigated the expression levels of individual human HDAC family members in pri...

2009
Yuan Lu Sarra L. Ryan David J. Elliott Graham R. Bignell P. Andrew Futreal David W. Ellison Simon Bailey Steven C. Clifford

BACKGROUND Medulloblastoma is the most common malignant brain tumour of childhood. The identification of critical genes involved in its pathogenesis will be central to advances in our understanding of its molecular basis, and the development of improved therapeutic approaches. METHODOLOGY/PRINCIPAL FINDINGS We performed a SNP-array based genome-wide copy number analysis in medulloblastoma cel...

Journal: :Cancer research 2008
Kimberly J Briggs Charles G Eberhart D Neil Watkins

Hypermethylated in cancer-1 (HIC1) is a tumor suppressor frequently targeted for promoter hypermethylation in medulloblastoma, an embryonal tumor of the cerebellum. Recently, we showed that HIC1 is a direct transcriptional repressor of ATOH1, a proneural transcription factor required for normal cerebellar development, as well as for medulloblastoma cell viability. Because demethylating agents c...

2013
Raffaella Spina Gessica Filocamo Enrico Iaccino Stefania Scicchitano Michela Lupia Emanuela Chiarella Tiziana Mega Francesca Bernaudo Daniela Pelaggi Maria Mesuraca Simonetta Pazzaglia Samantha Semenkow Eli E. Bar Marcel Kool Stefan Pfister Heather M. Bond Charles G. Eberhart Christian Steinkühler Giovanni Morrone

The stem cell-associated transcription co-factor ZNF521 has been implicated in the control of hematopoietic, osteo-adipogenic and neural progenitor cells. ZNF521 is highly expressed in cerebellum and in particular in the neonatal external granule layer that contains candidate medulloblastoma cells-of-origin, and in the majority of human medulloblastomas. Here we have explored its involvement in...

Journal: :AJNR. American journal of neuroradiology 2002
Yuichiro Naitoh Toshio Sasajima Hiroyuki Kinouchi Shigeki Mikawa Kazuo Mizoi

We present the case of an infant with medulloblastoma with extensive nodularity, which had been called cerebellar neuroblastoma. MR imaging clearly revealed a nodular enhancement, which appeared as a grape-like lesion. Single photon emission CT revealed markedly high iodine-123 metaiodobenzylguanidine uptake in the enhancing tumor. Iodine-123 metaiodobenzylguanidine single photon emission CT ma...

2017
Tao Xu Honglai Zhang Sung-Soo Park Sriram Venneti Rork Kuick Kimberly Ha Lowell Evan Michael Mariarita Santi Chiyoko Uchida Takafumi Uchida Ashok Srinivasan James M. Olson Andrzej A. Dlugosz Sandra Camelo-Piragua Jean-François Rual

Medulloblastoma is the most common malignant brain tumor in children. Therapeutic approaches to medulloblastoma (combination of surgery, radiotherapy, and chemotherapy) have led to significant improvements, but these are achieved at a high cost to quality of life. Alternative therapeutic approaches are needed. Genetic mutations leading to the activation of the Hedgehog pathway drive tumorigenes...

2017
Francisco Bautista Victoria Fioravantti Teresa de Rojas Fernando Carceller Luis Madero Alvaro Lassaletta Lucas Moreno

Survival rates for patients with medulloblastoma have improved in the last decades but for those who relapse outcome is dismal and new approaches are needed. Emerging drugs have been tested in the last two decades within the context of phase I/II trials. In parallel, advances in genetic profiling have permitted to identify key molecular alterations for which new strategies are being developed. ...

2015
Walderik W. Zomerman Sabine L. A. Plasschaert Sander H. Diks Harm-Jan Lourens Tiny Meeuwsen-de Boer Eelco W. Hoving Wilfred F. A. den Dunnen Eveline S. J. M. de Bont Jung Weon Lee

Recent clinical trials investigating receptor tyrosine kinase (RTK) inhibitors showed a limited clinical response in medulloblastoma. The present study investigated the role of micro-environmental growth factors expressed in the brain, such as HGF and EGF, in relation to the effects of hepatocyte growth factor receptor (MET) and epidermal growth factor receptor family (ErbB1-4) inhibition in me...

Journal: :Translational oncology 2010
Daniela Meco Tiziana Servidei Gian Franco Zannoni Enrica Martinelli Maria Grazia Prisco Chiara de Waure Riccardo Riccardi

Medulloblastoma is the most frequent malignant pediatric brain tumor with a dismal prognosis in 30% of cases. We examined the activity of AEE788, a dual inhibitor of human epidermal receptor (HER) 1/2 and vascular endothelial growth factor receptor (VEGFR) 1/2, in medulloblastoma preclinical models. Established lines (Daoy and D283), chemoresistant (Daoy(Pt)), and ectopically HER2-overexpressin...

2015
Claudia C. Faria Sameer Agnihotri Stephen C. Mack Brian J. Golbourn Roberto J. Diaz Samantha Olsen Melissa Bryant Matthew Bebenek Xin Wang Kelsey C. Bertrand Michelle Kushida Renee Head Ian Clark Peter Dirks Christian A. Smith Michael D. Taylor James T. Rutka

Advances in the molecular biology of medulloblastoma revealed four genetically and clinically distinct subgroups. Group 3 medulloblastomas are characterized by frequent amplifications of the oncogene MYC, a high incidence of metastasis, and poor prognosis despite aggressive therapy. We investigated several potential small molecule inhibitors to target Group 3 medulloblastomas based on gene expr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید